Orange Book product · Generic (ANDA)
DICLOXACILLIN SODIUM
DICLOXACILLIN SODIUM
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
DICLOXACILLIN SODIUM
Strength
EQ 125MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 061454
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DICLOXACILLIN SODIUM
- —PATHOCILBrand (NDA)
NDA 050011 · WYETH AYERST
- —DYNAPENBrand (NDA)
NDA 050337 · APOTHECON
- —PATHOCILBrand (NDA)
NDA 050092 · WYETH AYERST
- 2022DICLOXACILLIN SODIUMGeneric (ANDA)
ANDA 216845 · AUROBINDO PHARMA
- 1982DICLOXACILLIN SODIUMGeneric (ANDA)
ANDA 062286 · TEVA
- —DYCILLGeneric (ANDA)
ANDA 060254 · GLAXOSMITHKLINE
- —DYCILLGeneric (ANDA)
ANDA 062238 · GLAXOSMITHKLINE
- —DICLOXACILLIN SODIUMGeneric (ANDA)
ANDA 061455 · APOTHECON
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
